Genscript Biotech Corporation

GNNSF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$293,206$131,990$399,297$1,479,074
Short-Term Investments$103,989$489,195$1,474,638$481,516
Receivables$132,180$118,715$130,812$299,662
Inventory$38,802$31,097$50,836$53,332
Other Curr. Assets$45,051$63,981$158,740$72,068
Total Curr. Assets$1,176,806$834,978$2,214,323$2,353,111
Property Plant & Equip (Net)$597,882$602,838$813,715$750,741
Goodwill$1,341$1,336$1,347$1,356
Intangibles$12,772$13,035$16,078$18,648
Long-Term Investments$3,608,920$3,300,566$101,692$91,109
Tax Assets$0$27,735$0$16,502
Other NC Assets$36,885$497,781$184,712$173,430
Total NC Assets$4,257,800$4,443,291$1,117,544$1,051,786
Other Assets$0$0$0$0
Total Assets$5,434,606$5,278,269$3,331,867$3,386,383
Liabilities
Payables$51,728$29,838$59,205$39,959
Short-Term Debt$163,821$96,269$45,482$65,878
Tax Payable$0$14,739$15,574$18,127
Deferred Revenue$0$0$0$91,923
Other Curr. Liab.$384,980$166,496$412,736$278,790
Total Curr. Liab.$600,529$307,342$532,997$494,677
LT Debt$384,698$74,299$402,646$351,112
Deferred Rev, NC$0$0$2,704$47,949
Deferred Tax Liab, NC$13,708$5,839$7,509$5,620
Other NC Liab.$28,067$567,427$561,804$443,441
Total NC Liab.$412,765$647,565$974,663$848,137
Other Liabilities$0$0$0$0
Cap. Leases$63,168$64,514$112,057$72,772
Total Liabilities$1,013,294$954,907$1,507,660$1,342,948
Equity
Pref Stock$0$0$0$0
Common Stock$2,178$2,142$2,126$2,120
Retained Earnings$2,338,690$2,350,362-$772,840-$632,226
AOCI$95,587-$20,556$19,284$91,518
Other Equity$1,978,894$1,975,434$1,966,348$1,929,289
Total Equity$4,415,949$4,321,172$1,214,918$1,390,702
Supplemental Information
Minority Interest$5,363$2,190$609,289$653,098
Total Liab. & Tot. Equity$5,434,606$5,278,269$3,331,867$3,386,383
Net Debt$255,313$38,578$48,831-$1,062,084